Mirae Asset Global Investments Co., Ltd. Innoviva, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,425 shares of INVA stock, worth $41,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,425
Previous 2,088
16.14%
Holding current value
$41,831
Previous $37,000
29.73%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding INVA
# of Institutions
284Shares Held
80.3MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$124 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$108 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$82.1 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$74.1 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.2B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...